Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
ACADIA Pharmaceuticals Inc
SWB:DR6
ACADIA Pharmaceuticals Inc
SWB:DR6
Price:
23.37
EUR
4.94%
Market Closed
Market Cap:
€3.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
ACADIA Pharmaceuticals Inc
SWB:DR6
|
US |
|
O
|
Oji Holdings Corp
DUS:OJI
|
JP |
|
R
|
Ryanair Holdings PLC
DUS:RY4C
|
IE |
|
Yara International ASA
F:IU2
|
NO |
|
H
|
Haleon PLC
DUS:H6D0
|
UK |
Wall St Price Targets
DR6 Price Forecast
Based on 21 analysts
Based on 21 analysts
+36% Upside
from
€23.37
today
ACADIA Pharmaceuticals Inc (DR6)’s 12-month stock price forecast through August 2027 has a consensus target of €31.72, implying 36% upside. The forecast is based on price targets from 21 Wall Street analysts.
DR6 Analyst Rating
No ratings yet
No ratings yet
ACADIA Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DR6's stock price target?
Price Target
31.72
EUR
31.72
EUR
According to Wall Street analysts, the average 1-year price target for DR6 is 31.72 EUR with a low forecast of 14.83 EUR and a high forecast of 44.44 EUR.
What is the Revenue forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
9%
The compound annual growth rate for Revenue over the next 8 years is 9%.
What is the Gross Profit forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
9%
The compound annual growth rate for Gross Profit over the next 8 years is 9%.
What is the Operating Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
27%
27%
The compound annual growth rate for Operating Income over the next 8 years is 27%.
What is the Pre-Tax Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
33%
33%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 33%.
What is the Net Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
9%
The compound annual growth rate for Net Income over the next 8 years is 9%.